Nivolumab + Ipilimumab With and Without Local Therapy in Patients With Melanoma Brain Metastases
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Combined Immunotherapy With Nivolumab and Ipilimumab With and Without Local Therapy in Patients With Melanoma Brain Metastasis: A DeCOG* Study in 380 Patients
J Immunother Cancer 2020 Mar 01;8(1)e000333, T Amaral, F Kiecker, S Schaefer, H Stege, K Kaehler, P Terheyden, A Gesierich, R Gutzmer, S Haferkamp, J Uttikal, C Berking, D Rafei-Shamsabadi, L Reinhardt, F Meier, A Karoglan, C Posch, T Gambichler, C Pfoehler, K Thoms, J Tietze, D Debus, R Herbst, S Emmert, C Loquai, JC Hassel, F Meiss, T Tueting, V Heinrich, T Eigentler, C Garbe, L ZimmerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.